Total planned funding: $305,301,372
Clear active filters
U.S. Centers for Disease Control and Prevention
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $30,290,332 |
Uganda | $25,485,384 |
Tanzania | $24,478,092 |
Zambia | $23,029,043 |
Nigeria | $22,644,947 |
Ethiopia | $20,449,200 |
South Africa | $17,529,494 |
Kenya | $15,101,275 |
Côte d'Ivoire | $14,581,394 |
Haiti | $11,853,000 |
Botswana | $11,798,224 |
Namibia | $11,452,462 |
Asia Regional Program | $11,437,999 |
Rwanda | $11,161,000 |
Vietnam | $9,667,779 |
Zimbabwe | $8,281,702 |
Democratic Republic of the Congo | $6,256,258 |
Cameroon | $5,600,000 |
Malawi | $4,321,568 |
Western Hemisphere Region | $4,268,623 |
Eswatini | $3,311,174 |
Guyana | $2,272,643 |
West Africa Region | $2,007,237 |
Angola | $1,900,000 |
South Sudan | $1,786,827 |
Lesotho | $1,588,233 |
enumerations.Philippines | $1,000,000 |
Ukraine | $944,898 |
Dominican Republic | $802,584 |
Organizational Types
Own Agency | $305,301,372 |
Program Areas
Management and Operations | $152,589,664 |
Treatment | $80,000,327 |
Governance and Systems | $45,521,136 |
Prevention | $12,477,791 |
Care | $8,805,088 |
Testing | $5,907,366 |
Budget Codes
HVMS: Management and Operations | $152,589,664 |
HTXS: Treatment: Adult Treatment | $79,856,877 |
HVSI: Strategic Information | $22,203,784 |
HLAB: Laboratory Infrastructure | $12,723,793 |
OHSS: Health Systems Strengthening | $10,593,559 |
HVCT: Testing: HIV Testing and Counseling | $5,907,366 |
HVTB: Care: TB/HIV | $4,466,693 |
HVOP: Sexual Prevention: Other Sexual Prevention | $3,767,688 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,650,944 |
HBHC: Care: Adult Care and Support | $2,730,231 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,655,588 |
HKID: Care: Orphans and Vulnerable Children | $1,542,140 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $1,277,244 |
HMBL: Biomedical Prevention: Blood Safety | $1,058,680 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $595,647 |
HMIN: Biomedical Prevention: Injection Safety | $472,000 |
HTXD: Treatment: ARV Drugs | $143,450 |
PDCS: Care: Pediatric Care and Support | $66,024 |